ALFA Finder| Metric | H1 FY27 | H2 FY26 | H1 FY26 |
|---|---|---|---|
| Revenue from operations | 3.0 | 9.6 | 4.1 |
| Other income | 0.1 | 0.1 | 0.1 |
| Total income | 3.0 | 9.6 | 4.1 |
| Profit before exceptional items & tax | -0.5 | 1.8 | 0.1 |
| Profit before tax | -0.5 | 1.8 | 0.1 |
| Net profit | -0.4 | 1.4 | 0.1 |
| Operating margin | -16.7% | 18.8% | 2.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | -26.80% |
|---|---|
| Operating profit, quarter on quarter | -135.30% |
BSE results filing, BSE: 543595. Figures extracted from the filing.
EP Biocomposites Ltd: key numbers
- Share price
- ₹99.32
- Market cap
- ₹16.70 Cr
- Revenue (annual)
- ₹13.64 Cr
- Net profit (annual)
- ₹1.46 Cr
- P/E (TTM)
- 11.4×Sector 21.5×
- Promoter holding
- 70.08%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from EP Biocomposites Ltd
All →EP Biocomposites Other Announcement
This filing submits the quarterly shareholding pattern for EP Biocomposites Ltd as required under Regulation 31(1)(b) of SEBI LODR Regulations.
EP Biocomposites Partnership
EP Biocomposites signed a strategic collaboration and consultancy agreement with Malligavad Foundation and Anand Malligavad for water conservation projects, with no upfront monetary consideration.
EP Biocomposites Bags ₹0.92 Cr Order from Beleza by the Beach
EP Biocomposites Limited secured a ₹0.92 Crore order from Beleza by the Beach to install a 70 KLD Sewage Treatment Plant by April 2027.
- Value
- ₹0.92 Cr
- From
- Beleza by the Beach
- Execution
- 30.04.2027
- Sewage Treatment Plant
- 70.0 KLD
EP Biocomposites Annual General Meeting
EP Biocomposites has shared the draft Chairman’s speech for its 7th Annual General Meeting on September 28, 2026. It highlights recent financial performance and strategic initiatives.
EP Biocomposites Investor Presentation: Key Takeaways
EP Biocomposites Limited reported FY26 revenue of ₹1,363.98 lakhs with a 10.69% PAT margin. The company is pivoting towards sustainable infrastructure solutions including bio-digesters and wastewater treatment.
EP Biocomposites Annual Report
EP Biocomposites Ltd has released its 7th Annual Report for the financial year 2025-26, detailing operational highlights and financial performance snapshots.